Warning letter
Lazarus Dermatologic Products: warning letter of Apr 21, 1998
FDA warning letter UCM066429 · Los Angeles District Office
Key facts
| Reference number | UCM066429 |
|---|---|
| Company | Lazarus Dermatologic Products |
| Subject | Drug Products |
| Issue date | Apr 21, 1998 |
| Posted date | Apr 21, 1998 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: